These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16187693)

  • 1. The liver X receptors.
    Lala DS
    Curr Opin Investig Drugs; 2005 Sep; 6(9):934-43. PubMed ID: 16187693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological role of liver X receptors.
    Baranowski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic opportunities for liver X receptor modulators.
    Collins JL
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of LXR.
    Michael LF; Schkeryantz JM; Burris TP
    Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptors as integrators of metabolic and inflammatory signaling.
    Zelcer N; Tontonoz P
    J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver x receptors: potential novel targets in cardiovascular diseases.
    Bruemmer D; Law RE
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):533-40. PubMed ID: 16503873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptors as therapeutic targets in metabolism and atherosclerosis.
    Nomiyama T; Bruemmer D
    Curr Atheroscler Rep; 2008 Feb; 10(1):88-95. PubMed ID: 18366990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective liver X receptor modulators (SLiMs): what use in human health?
    Viennois E; Mouzat K; Dufour J; Morel L; Lobaccaro JM; Baron S
    Mol Cell Endocrinol; 2012 Apr; 351(2):129-41. PubMed ID: 21907760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X receptors and atherosclerosis.
    Lala DS
    IDrugs; 2004 Jun; 7(6):563-9. PubMed ID: 15197661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in liver X receptor biology and chemistry.
    Goodwin BJ; Zuercher WJ; Collins JL
    Curr Top Med Chem; 2008; 8(9):781-91. PubMed ID: 18537688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting liver X receptors in human health: deadlock or promising trail?
    Viennois E; Pommier AJ; Mouzat K; Oumeddour A; El Hajjaji FZ; Dufour J; Caira F; Volle DH; Baron S; Lobaccaro JM
    Expert Opin Ther Targets; 2011 Feb; 15(2):219-32. PubMed ID: 21204733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential.
    Gong H; Xie W
    Expert Opin Ther Targets; 2004 Feb; 8(1):49-54. PubMed ID: 14996618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.
    Smoak K; Madenspacher J; Jeyaseelan S; Williams B; Dixon D; Poch KR; Nick JA; Worthen GS; Fessler MB
    J Immunol; 2008 Mar; 180(5):3305-12. PubMed ID: 18292555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
    Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
    Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications.
    Jamroz-Wiśniewska A; Wójcicka G; Horoszewicz K; Bełtowski J
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():760-85. PubMed ID: 18063919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nuclear strike against Listeria--the evolving life of LXR.
    Barish GD; Evans RM
    Cell; 2004 Oct; 119(2):149-51. PubMed ID: 15479632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.
    Rigamonti E; Chinetti-Gbaguidi G; Staels B
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1050-9. PubMed ID: 18323516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergence of lipid homeostasis through liver X and thyroid hormone receptors.
    Berkenstam A; Färnegårdh M; Gustafsson JA
    Mech Ageing Dev; 2004; 125(10-11):707-17. PubMed ID: 15541766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.